Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis

By afschroeder • February 12, 2026

Ibrahim M, Tariq S, Afridi MK, Zafar A, Khamisani FA, Aminpoor H, Arfin SMW, Fonarow GC, Greene SJ, Musani MH, Waqas SA. Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes: A Systematic Review and Meta-Analysis. Clin Appl Thromb Hemost. 2026 Jan-Dec;32:10760296261422490. doi: 10.1177/10760296261422490. Epub 2026 Feb 11. PMID: 41671172.

Tags: acute coronary syndrome, Cardiology/Epi, dual antiplatelet therapy, meta-analysis, P2Y12 inhibitor, percutaneous coronary intervention, Publications

Racial and Ethnic Differences in Transcatheter Coarctation Repair among Adolescents and Adults

Bravo-Jaimes K, Lopez K, Aboulhosn J, Kennedy K, McLeod C, Bullock-Palmer RP. Racial and Ethnic Differences in Transcatheter Coarctation Repair among Adolescents and Adults. Am[...]

A National Institute on Aging workshop on sex differences in health across the lifespan

Pea J, Addie S, Ambrosio F, Anderson RM, Bairey Merz CN, Barr E, Carrington-Lawrence S, de Cabo R, Desvigne-Nickens P, Dubal DB, Haakenson C, Hargove-Grimes[...]

Association between adverse pregnancy outcomes and awareness of cardiovascular risk factors: A nuMoM2b-HHS secondary analysis

Wendl EM, Allshouse AA, Goodwin A, Hobbs B, Greenland P, Levine L, Grobman W, Saade GR, Cameron N, Merz CNB, Rouse C, Rogan S, Chung[...]